Parkinsonism & Related Disorders

Papers
(The H4-Index of Parkinsonism & Related Disorders is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Objective sleep enhancement in Parkinson's disease: A sham-controlled trial of low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex96
Cerebello-thalamofrontal dysconnectivity in paroxysmal kinesigenic dyskinesia: A resting-state fMRI study93
Perry disease in an Argentine family due to the DCTN1 p.G67D variant57
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?55
Is rapid eye movement sleep behavior disorder a marker of Parkinson's disease severity?54
Postural abnormalities in Asian and Caucasian Parkinson's disease patients: A multicenter study48
Magnetic resonance spectroscopy reveals evidence of brain oxidative stress in Tourette syndrome46
Fear among patients with Parkinson's disease and repeated falls: Analysis of skin conductance responses during simulated accidents46
A useful cognitive motor dual task paradigm in prodromal and manifest Huntington’s disease44
Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia43
Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: analysis of baseline factors43
Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder43
Critical Appraisal of Economic Evaluation of Biomarkers Used for Screening of Dementia42
A novel summary index derived from Kinect to evaluate the severity of postural abnormalities in patients with Parkinson’s Disease41
Early onset hemichorea-parkinsonism with POLG mutation without external ophthalmoplegia responsive to pallidal DBS39
White matter connectivity networks predict early dementia conversion in Parkinson’s disease38
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease37
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease37
Chorea-Acanthocytosis: A Case Report36
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention35
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment35
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease34
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.34
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease32
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome32
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder31
Bilateral Hemimasticatory spasm in a patient with hypereosinophilic syndrome30
Treatment of refractory post-hypoxic myoclonus and focal epilepsy with subthalamic nuclei deep brain stimulation29
Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysis28
Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?28
Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyse28
0.097162961959839